Kahremany Shirin, Livne Ariela, Gruzman Arie, Senderowitz Hanoch, Sasson Shlomo
Division of Medicinal Chemistry, Department of Chemistry, Faculty of Exact Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Br J Pharmacol. 2015 Feb;172(3):754-70. doi: 10.1111/bph.12950. Epub 2014 Dec 15.
PPARδ is a ligand-activated receptor that dimerizes with another nuclear receptor of the retinoic acid receptor family. The dimers interact with other co-activator proteins and form active complexes that bind to PPAR response elements and promote transcription of genes involved in lipid metabolism. It appears that various natural fatty acids and their metabolites serve as endogenous activators of PPARδ; however, there is no consensus in the literature on the nature of the prime activators of the receptor. In vitro and cell-based assays of PPARδ activation by fatty acids and their derivatives often produce conflicting results. The search for synthetic and selective PPARδ agonists, which may be pharmacologically useful, is intense. Current rational modelling used to obtain such compounds relies mostly on crystal structures of synthetic PPARδ ligands with the recombinant ligand binding domain (LBD) of the receptor. Here, we introduce an original computational prediction model for ligand binding to PPARδ LBD. The model was built based on EC50 data of 16 ligands with available crystal structures and validated by calculating binding probabilities of 82 different natural and synthetic compounds from the literature. These compounds were independently tested in cell-free and cell-based assays for their capacity to bind or activate PPARδ, leading to prediction accuracy of between 70% and 93% (depending on ligand type). This new computational tool could therefore be used in the search for natural and synthetic agonists of the receptor.
PPARδ是一种配体激活受体,它与视黄酸受体家族的另一种核受体形成二聚体。这些二聚体与其他共激活蛋白相互作用,形成活性复合物,该复合物与PPAR反应元件结合并促进参与脂质代谢的基因转录。各种天然脂肪酸及其代谢产物似乎可作为PPARδ的内源性激活剂;然而,关于该受体主要激活剂的性质,文献中尚无共识。脂肪酸及其衍生物对PPARδ激活的体外和基于细胞的测定常常产生相互矛盾的结果。对可能具有药理学用途的合成和选择性PPARδ激动剂的研究正在激烈进行。目前用于获得此类化合物的合理建模主要依赖于合成PPARδ配体与受体重组配体结合域(LBD)的晶体结构。在此,我们介绍一种用于配体与PPARδ LBD结合的原创计算预测模型。该模型基于16种具有可用晶体结构的配体的EC50数据构建,并通过计算文献中82种不同天然和合成化合物的结合概率进行验证。这些化合物在无细胞和基于细胞的测定中独立测试其结合或激活PPARδ的能力,预测准确率在70%至93%之间(取决于配体类型)。因此,这种新的计算工具可用于寻找该受体的天然和合成激动剂。